Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever

Ahsan, 2019, Azithromycin resistance in clinical isolates of Salmonella enterica serovars Typhi and Paratyphi in Bangladesh, Microb. Drug Resist., 25, 8, 10.1089/mdr.2018.0109 Bhattacharya, 2011, Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa, Indian J. Med. Res., 133, 431 bioMérieux, 2012. Etest Antimicrobial Susceptibility Testing, p. 1–6. Blumentrath, 2019, Relapse of typhoid fever following delayed response to meropenem: A case report and review of previously published cases indicating limited clinical efficacy of meropenem for the treatment of typhoid fever, GMS Ger. Med. Sci., 17 Butler, 1999, Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India, J. Antimicrob. Chemother., 44, 243, 10.1093/jac/44.2.243 Chatham-Stephens, 2019, Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan - United States, 2016–2018, Morb. Mortal Wkly. Rep., 68, 11, 10.15585/mmwr.mm6801a3 Clinical and Laboratory Standards Institute, 2019. M100: Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. Day, 2018, Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi, J. Antimicrob. Chemother., 73, 365, 10.1093/jac/dkx379 Goldblatt, 2020, Azithromycin susceptibility testing for Salmonella enterica isolates: Discordances in results using MIC gradient strips, J. Antimicrob. Chemother., 75, 1820, 10.1093/jac/dkaa097 Klemm, 2018, Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins, mBio, 9, e00105, 10.1128/mBio.00105-18 Liu, 2020, The first imported case of extensively drug-resistant Salmonella enterica serotype Typhi infection in Taiwan and the antimicrobial therapy, J. Microbiol. Immunol. Infect., 10.1016/j.jmii.2020.03.017 McArthur, 2013, The comprehensive antibiotic resistance database, Antimicrob. Agents Chemother., 57, 3348, 10.1128/AAC.00419-13 Molloy, 2010, First report of Salmonella enterica serotype Paratyphi A azithromycin resistance leading to treatment failure, J. Clin. Microbiol., 48, 4655, 10.1128/JCM.00648-10 Munir, 2016, Extended spectrum beta lactamase producing cephalosporin resistant Salmonella Typhi, reported from Rawalpindi, Pakistan, J. Pak. Med. Assoc., 66, 1035 Patel, 2017, Drug resistance pattern in the recent isolates of Salmonella Typhi with special reference to cephalosporins and azithromycin in the Gangetic plain, J. Clin. Diagnostic Res., 11, DM01 Qamar, 2014, A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan, J. Infect. Dev. Ctries, 8, 981, 10.3855/jidc.3817 Saha, 1999, A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh, Pediatr. Infect. Dis. J., 18, 387, 10.1097/00006454-199904000-00018 Sharma, 2019, Azithromycin resistance mechanisms in typhoidal salmonellae in India: A 25 years analysis, Indian J. Med. Res., 404 The European Committee on Antimicrobial Susceptibility Testing, 2019. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. Version 9.0 2019. Trivedi, 2012, A meta-analysis comparing the safety and efficacy of azithromycin over the alternate drugs used for treatment of uncomplicated enteric fever, J. Postgrad. Med., 58, 112, 10.4103/0022-3859.97172 Zankari, 2012, Identification of acquired antimicrobial resistance genes, J. Antimicrobial Chemother., 67, 2640, 10.1093/jac/dks261